Evaluation of the safety and immunogenicity of the oral inactivated multivalent enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi adults in a double-blind, randomized, placebo-controlled Phase I trial using electrochemiluminescence and ELISA assays for immunogenicity analyses-Reference-Cited by-同舟云学术

Evaluation of the safety and immunogenicity of the oral inactivated multivalent enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi adults in a double-blind, randomized, placebo-controlled Phase I trial using electrochemiluminescence and ELISA assays for immunogenicity analyses

Published:2019-09 Issue:37 Volume:37 Page:5645-5656
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Akhtar Marjahan,Chowdhury Mohiul I.,Bhuiyan Taufiqur R.,Kaim Joanna,Ahmed Tasnuva,Rafique Tanzeem A.,Khan Arifuzzaman,Rahman Sadia I.A.,Khanam Farhana,Begum Yasmin A.,Sharif Mir Z.,Islam Laila N.,Carlin Nils,Maier Nicole,Fix Alan,Wierzba Thomas F.^ORCID,Walker Richard I.,Bourgeois A. Louis,Svennerholm Ann-Mari,Qadri Firdausi,Lundgren Anna

Funder

PATH

Bill and Melinda Gates Foundation

Swedish Research Council

British Department of International Development

Swedish Foundation for Strategic Research

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference47 articles.

1. Enterotoxigenic Escherichia coli in developing countries: epidemiology, microbiology, clinical features, treatment, and prevention;Qadri;Clin Microbiol Rev,2005